Pan-cancer association between increased iron utilization and poor prognosis highlights potential of transferrin receptor-targeting therapies in multiple tumor types | Caris Life Sciences
Home / Research / Publications / Pan-cancer association between increased iron utilization and poor prognosis highlights potential of transferrin receptor-targeting therapies in multiple tumor types

Publications

Pan-cancer association between increased iron utilization and poor prognosis highlights potential of transferrin receptor-targeting therapies in multiple tumor types

Key Finding:

Except for vulvar squamous cell carcinoma, TFRC over-expression is associated with worse overall survival in 23 tumor types. 

Download Publication
Learn More
Name(Required)